University of Saskatchewan
Saskatoon, Saskatchewan, S7N0W8, Canada
NCT Number: NCT02327234
The study will assess airway responses in mild atopic asthmatics undergoing repeat allergen challenge testing and will investigate whether ibuprofen changes the response.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Saskatoon, Saskatchewan, S7N0W8, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2x 200mg ibuprofen, single dose, blinded in 00 capsules
Other names: Advil
lactose filled 00 capsules to match appearance of ibuprofen intervention
Time frame: at time of allergen inhalation challenge and for 7 hours after
area under forced expiratory volume in one second versus time curve; 0-3hours (early response) and 3-7 hours (late response)
Time frame: day before allergen inhalation challenge and 8 hours after allergen inhalation challenge
delta log methacholine PC20 (provocative concentration of methacholine causing a 20% decrease in the forced expiratory volume in one second)
University of Saskatchewan
Other
Assessment of Repeated Allergen Challenge and the Effects of Ibuprofen on the Inflammatory Process
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04728711
Atopic Asthma
Mississauga, Ontario, Canada
View Trial DetailsNCT05098600
Abnormalities, Multiple, Alopecia
Prague, Czechia
View Trial DetailsNCT03603522
Atopic Asthma, Cough
Hamilton, Ontario, Canada
View Trial DetailsNCT03665701
Atopic Asthma
Hanover, Lower Saxony, Germany
View Trial Details